GEP20156216B - Heterocyclic compound and usage thereof - Google Patents

Heterocyclic compound and usage thereof

Info

Publication number
GEP20156216B
GEP20156216B GEAP201113021A GEAP2011013021A GEP20156216B GE P20156216 B GEP20156216 B GE P20156216B GE AP201113021 A GEAP201113021 A GE AP201113021A GE AP2011013021 A GEAP2011013021 A GE AP2011013021A GE P20156216 B GEP20156216 B GE P20156216B
Authority
GE
Georgia
Prior art keywords
usage
heterocyclic compound
амра
isoxasole
schizophrenia
Prior art date
Application number
GEAP201113021A
Other languages
English (en)
Inventor
Michiyo Mochizuki
Osamu Ujikawa
Yasutomi Asano
Eiji Honda
Masashi Toyofuku
Shinji Nakamura
Toshihiro Imaeda
Masakuni Kori
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of GEP20156216B publication Critical patent/GEP20156216B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GEAP201113021A 2010-08-10 2011-08-09 Heterocyclic compound and usage thereof GEP20156216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
GEP20156216B true GEP20156216B (en) 2015-01-12

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201113021A GEP20156216B (en) 2010-08-10 2011-08-09 Heterocyclic compound and usage thereof

Country Status (39)

Country Link
US (11) US9150591B2 (enExample)
EP (1) EP2603513B1 (enExample)
JP (2) JP5788496B2 (enExample)
KR (1) KR101852215B1 (enExample)
CN (2) CN103180326B (enExample)
AR (1) AR082618A1 (enExample)
AU (1) AU2011290126B2 (enExample)
BR (1) BR112013002250B1 (enExample)
CA (1) CA2807460C (enExample)
CL (1) CL2013000380A1 (enExample)
CO (1) CO6680700A2 (enExample)
CR (1) CR20130066A (enExample)
CY (1) CY1123507T1 (enExample)
DK (1) DK2603513T3 (enExample)
DO (1) DOP2013000030A (enExample)
EA (1) EA022078B1 (enExample)
EC (1) ECSP13012478A (enExample)
ES (1) ES2793723T3 (enExample)
GE (1) GEP20156216B (enExample)
HR (1) HRP20200844T1 (enExample)
HU (1) HUE049460T2 (enExample)
IL (1) IL224452A (enExample)
LT (1) LT2603513T (enExample)
MA (1) MA34509B1 (enExample)
MX (1) MX349470B (enExample)
MY (1) MY165908A (enExample)
NZ (1) NZ607593A (enExample)
PE (1) PE20131116A1 (enExample)
PH (1) PH12013500247A1 (enExample)
PL (1) PL2603513T3 (enExample)
PT (1) PT2603513T (enExample)
RS (1) RS60311B1 (enExample)
SG (1) SG187656A1 (enExample)
SI (1) SI2603513T1 (enExample)
TW (1) TWI504604B (enExample)
UA (1) UA111594C2 (enExample)
UY (1) UY33551A (enExample)
WO (1) WO2012020848A1 (enExample)
ZA (1) ZA201301120B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788496B2 (ja) * 2010-08-10 2015-09-30 武田薬品工業株式会社 複素環化合物およびその用途
WO2012137982A2 (en) * 2011-04-05 2012-10-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
EP3311842A1 (en) * 2013-06-13 2018-04-25 VeroScience LLC Compositions and methods for treating metabolic disorders
DK3013813T3 (da) 2013-06-27 2019-06-03 Pfizer Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
JP6524086B2 (ja) 2013-12-03 2019-06-05 エフ エム シー コーポレーションFmc Corporation ピロリジノン除草剤
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
EP3164386B1 (en) 2014-07-02 2020-10-07 FMC Corporation Piperidinone herbicides
EP3230264B1 (en) 2014-12-08 2019-09-11 FMC Corporation 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
EP3280709B1 (en) 2015-04-10 2021-05-26 FMC Corporation Substituted cyclic amides as herbicides
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
MX373652B (es) * 2015-04-29 2020-04-02 Janssen Pharmaceutica Nv Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
WO2016176460A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
PL3294743T3 (pl) 2015-05-12 2020-03-31 Fmc Corporation Podstawione arylem związki bicykliczne jako środki chwastobójcze
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
US10654804B2 (en) 2015-06-02 2020-05-19 Fmc Corporation Substituted cyclic amides and their use as herbicides
AU2016303209B2 (en) 2015-07-31 2021-04-01 Fmc Corporation Cyclic N-carboxamide compounds useful as herbicides
CA2982825C (en) * 2015-08-06 2023-10-17 F. Hoffmann-La Roche Ag Processes for the preparation of galnac acid derivatives
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
EP3558962B1 (en) 2016-12-21 2023-07-12 FMC Corporation Nitrone herbicides
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
BR112019019551A2 (pt) 2017-03-21 2020-04-22 Fmc Corp mistura, e, método para controlar o crescimento de vegetação indesejada
SG11201908640TA (en) 2017-03-21 2019-10-30 Fmc Corp Pyrrolidinones and a process to prepare them
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
US11447488B2 (en) 2017-10-06 2022-09-20 Takeda Pharmaceutical Company Limited Heterocyclic compounds
JP7250686B2 (ja) * 2017-10-06 2023-04-03 武田薬品工業株式会社 複素環化合物
US12370192B2 (en) 2019-09-16 2025-07-29 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
WO2021229294A1 (en) 2020-05-15 2021-11-18 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226591A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Methods of administering 9-[4-(cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide without side effects

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (enExample) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
WO2001032013A1 (en) 1999-11-04 2001-05-10 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1436270A1 (en) * 2001-10-10 2004-07-14 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007100527A4 (en) 2006-06-23 2007-08-23 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
KR20090082278A (ko) 2006-12-11 2009-07-29 일라이 릴리 앤드 캄파니 Ampa 수용체 강화제
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
US8487099B2 (en) * 2007-11-05 2013-07-16 Merck Sharp & Dohme Corp. Gamma secretase modulators
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP2269990A4 (en) 2008-03-25 2012-04-18 Takeda Pharmaceutical Heterocyclic compound
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
JP2012508181A (ja) * 2008-11-06 2012-04-05 シェーリング コーポレイション γ−セクレターゼ調節剤
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
WO2011007756A1 (ja) 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
JP5788496B2 (ja) * 2010-08-10 2015-09-30 武田薬品工業株式会社 複素環化合物およびその用途

Also Published As

Publication number Publication date
TW201217386A (en) 2012-05-01
BR112013002250A2 (pt) 2016-05-24
US8778934B2 (en) 2014-07-15
PH12013500247A1 (en) 2013-03-11
AU2011290126A1 (en) 2013-03-07
US20120077799A1 (en) 2012-03-29
JP5788496B2 (ja) 2015-09-30
CA2807460A1 (en) 2012-02-16
CR20130066A (es) 2013-05-03
KR101852215B1 (ko) 2018-04-25
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
US8575154B2 (en) 2013-11-05
EP2603513A1 (en) 2013-06-19
NZ607593A (en) 2015-01-30
US20180162875A1 (en) 2018-06-14
CN104926837A (zh) 2015-09-23
EA201390222A1 (ru) 2013-08-30
US10654874B2 (en) 2020-05-19
EA022078B1 (ru) 2015-10-30
HRP20200844T1 (hr) 2020-08-21
US20170022222A1 (en) 2017-01-26
LT2603513T (lt) 2020-05-25
DOP2013000030A (es) 2013-03-15
MY165908A (en) 2018-05-18
CY1123507T1 (el) 2022-03-24
JP2016006080A (ja) 2016-01-14
US20130190291A1 (en) 2013-07-25
DK2603513T3 (da) 2020-06-15
US20150073137A1 (en) 2015-03-12
ZA201301120B (en) 2014-04-30
WO2012020848A1 (en) 2012-02-16
CA2807460C (en) 2018-09-18
AR082618A1 (es) 2012-12-19
US9499568B2 (en) 2016-11-22
RS60311B1 (sr) 2020-07-31
US20240360156A1 (en) 2024-10-31
SG187656A1 (en) 2013-03-28
CN103180326A (zh) 2013-06-26
KR20130138738A (ko) 2013-12-19
UY33551A (es) 2012-03-30
ECSP13012478A (es) 2013-04-30
US9150591B2 (en) 2015-10-06
MX2013001614A (es) 2013-07-05
JP2013535408A (ja) 2013-09-12
US20150353578A1 (en) 2015-12-10
IL224452A (en) 2017-11-30
EP2603513B1 (en) 2020-03-11
PL2603513T3 (pl) 2020-07-27
CN103180326B (zh) 2015-06-10
US8916551B2 (en) 2014-12-23
PE20131116A1 (es) 2013-10-24
CL2013000380A1 (es) 2013-05-31
PT2603513T (pt) 2020-06-08
MA34509B1 (fr) 2013-09-02
CO6680700A2 (es) 2013-05-31
US20130184266A1 (en) 2013-07-18
US20200317692A1 (en) 2020-10-08
US20190263832A1 (en) 2019-08-29
AU2011290126B2 (en) 2016-01-07
US9884875B2 (en) 2018-02-06
TWI504604B (zh) 2015-10-21
HUE049460T2 (hu) 2020-09-28
ES2793723T3 (es) 2020-11-16
BR112013002250B1 (pt) 2020-10-27
WO2012020848A8 (en) 2012-09-27
JP6113789B2 (ja) 2017-04-12
US20140080817A1 (en) 2014-03-20
MX349470B (es) 2017-07-31
US11279713B2 (en) 2022-03-22

Similar Documents

Publication Publication Date Title
GEP20156216B (en) Heterocyclic compound and usage thereof
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
NZ593004A (en) Azaazulene compounds
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
EA019970B8 (ru) Производные имидазолидиндиона
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
GEP20146072B (en) New compounds
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX2012000973A (es) Compuestos para la reduccion de produccion de beta- amiloide.
GEP20146124B (en) Novel ccr2 receptor antagonists and usage thereof
EA201071144A1 (ru) Гетероциклические производные
NZ601121A (en) 5-alkynyl-pyrimidines
GEP20166554B (en) Nitrogenated heterocyclic compound
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
TN2011000368A1 (en) Fused ring compound and use thereof
WO2008113559A3 (en) Indolizines and aza-analog derivatives thereof as cns active compounds
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
GEP20146099B (en) Fused imidazole carboxamides as trpv3 modulators
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
TW200738651A (en) Cyclohexyl sulfonamide derivatives
EP2578587A4 (en) PYRAZOLE DERIVATIVES
UA104867C2 (uk) Похідні феноксихроманкарбонової кислоти, заміщені в 6-ому положенні
SE0800742L (sv) Vikttäcke